Novel pilocarpine formulation drop appears effective for presbyopia
In this phase 3 trial, Allergan’s AGN-190584 topical pilocarpine drops show promise for the treatment of presbyopia. Source: AAO
- Posted on: Feb 21 2023
- Leave a response
In this phase 3 trial, Allergan’s AGN-190584 topical pilocarpine drops show promise for the treatment of presbyopia. Source: AAO
Investigators set out to assess the geographical distribution (number and location) of pediatric ophthalmologists in the US in relation to population demographic characteristics. Source: AAO
Performing cataract surgery could lead to clinician burnout, a healthy lifestyle offsets risk of glaucoma-related cardiovascular disease, and extracellular vesicles may be a keratoconus marker. Source: AAO
Corneal crosslinking appears to show long-term effectiveness in slowing keratoconus progression in a pediatric population. Source: AAO
Inflammatory ocular adverse events are a rare but not unknown complication of treatment with checkpoint inhibitors. Source: AAO
To date, there have been few data published focusing on the effectiveness of oral fluorescein angiography for differentiating papilledema from pseudopapilledema Source: AAO
This prospective case-control study evaluated the sensitivity and specificity of syphilis antibody testing in vitreous samples in order to determine its feasibility as a diagnostic test for syphilitic uveitis. Source: AAO
In children with albinism, foveal hypoplasia may be linked to additional retinal development occurring after birth. Source: AAO
Visual acuity outcomes after rhegmatogenous retinal detachment (RRD) repair appear linked to the timing between symptom onset and surgery. Source: AAO
Dry eye disease can affect a person’s job performance, saturated fat could lower AMD risk in men, and diastolic blood pressure is studied as a potential glaucoma measure. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »